Hemocompatibility of polymeric nanostructured surfaces

Journal of Biomaterials Science, Polymer Edition

Volumn 24, Issue 13, 2013, Pages 1529-1548

  Leszczak, Victoria ^a   Smith, Barbara S ^a   Popat, Ketul C ^a  

^a Department of Chemical and Biological Engineering and School of Biomedical Engineering   (United States)

Author keywords

hemocompatibility; nanofiber surfaces; nanowire surfaces; platelets

Indexed keywords

ACTIVATED PLATELETS; BIOMATERIAL SURFACES; HEMOCOMPATIBILITY; NANOSTRUCTURED SURFACE; NANOWIRE SURFACE; PLATELET ACTIVATION; PROTEIN ADSORPTION; SIGNIFICANT DIFFERENCES;

ADSORPTION; CELL ADHESION; NANOFIBERS; NANOWIRES; PLATELETS; POLYCAPROLACTONE; STAINLESS STEEL;

POLYMERS;

ACTIVATION INDUCED CYTIDINE DEAMINASE; ALBUMIN; FIBRINOGEN; HEMOGLOBIN; IMMUNOGLOBULIN G; NANOFIBER; NANOMATERIAL; NANOWIRE; PLASMA PROTEIN; POLYCAPROLACTONE; POLYMER;

ADSORPTION; ARTICLE; BLOOD CLOTTING; BLOOD COMPATIBILITY; BLOOD COMPONENT; CELL VIABILITY; COLORIMETRY; CONTACT ANGLE; FLUORESCENCE MICROSCOPY; HEMOLYSIS; HUMAN; HUMAN CELL; NANOFABRICATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; X RAY PHOTOELECTRON SPECTROSCOPY;

ADSORPTION; BIOCOMPATIBLE MATERIALS; BLOOD COAGULATION; BLOOD PROTEINS; FIBRINOGEN; HUMANS; IMMUNOGLOBULIN G; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; NANOFIBERS; NANOSTRUCTURES; NANOWIRES; PLATELET ACTIVATION; POLYESTERS; SERUM ALBUMIN; SURFACE PROPERTIES;

EID: 84880465456     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1080/09205063.2013.777228     Document Type: Article

References (68)

1. Smith SC, Jr. Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). J. Am. College Cardiol. 2012;60:2343-2348.
2. Nugent HM, Edelman ER. Tissue engineering therapy for cardiovascular disease. Circulat. Res. 2003;92:1068-1078.
3. Seyednejad H, Gawlitta D, Kuiper RV, de Bruin A, van Nostrum CF, Vermonden T, Dhert WJ, Hennink WE. In vivo biocompatibility and biodegradation of 3D-printed porous scaffolds based on a hydroxyl-functionalized poly(?-caprolactone). Biomaterials. 2012;33:4309-4318.
4. Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart. 2003;89:651-656.
5. van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HMM, Serruys PW, Holmes DR, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation. 1996;94:1690-1697.
6. Zhang Y, Ouyang H, Lim CT, Ramakrishna S, Huang Z-M. Electrospinning of gelatin fibers and gelatin/ PCL composite fibrous scaffolds. J. Biomed. Mater. Res., Part B: Appl. Biomater. 2005;72B:156-165.
7. Ajili SH, Ebrahimi NG, Soleimani M. Polyurethane/polycaprolactane blend with shape memory effect as a proposed material for cardiovascular implants. Acta Biomater. 2009;5:1519-1530.
8. Kim HI, Ishihara K, Lee S, Seo J-H, Kim HY, Suh D, Kim MU, Konno T, Takai M, Seo JS. Tissue response to poly(l-lactic acid)-based blend with phospholipid polymer for biodegradable cardiovascular stents. Biomaterials. 2011;32:2241-2247.
9. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, Langer R, Vacanti JP, Mayer JE, Jr. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation. 1996;94:II164-II168.
10. Andukuri A, Kushwaha M, Tambralli A, Anderson JM, Dean DR, Berry JL, Sohn YD, Yoon YS, Brott BC, Jun HW. A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants. Acta Biomater. 2011;7:225-233.
11. Motlagh D, Allen J, Hoshi R, Yang J, Lui K, Ameer G. Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. J. Biomed. Mater. Res. Part A. 2007;82A:907-916.
12. Belanger MC, Marois Y, Roy R, Mehri Y, Wagner E, Zhang Z, et al. Selection of a polyurethane membrane for the manufacture of ventricles for a totally implantable artificial heart: blood compatibility and biocompatibility studies. Artif. Org. 2000;24:879-888.
13. Maegdefessel L, Linde T, Krapiec F, Hamilton K, Steinseifer U, van Ryn J, Raaz U, Buerke M, Werdan K, Schlitt A. In vitro comparison of dabigatran, unfractionated heparin, and low-molecularweight heparin in preventing thrombus formation on mechanical heart valves. Thrombos. Res. 2010;126:e196-e200.
14. Motlagh D, Yang J, Lui KY, Webb AR, Ameer GA. Hernocompatibility evaluation of poly(glycerolsebacate) in vitro for vascular tissue engineering. Biomaterials. 2006;27:4315-4324.
15. Baker DW, Liu X, Weng H, Luo C, Tang L. Fibroblast/fibrocyte: surface interaction dictates tissue reactions to micropillar implants. Biomacromolecules. 2011;12:997-1005.
16. Muthusubramaniam L, Lowe R, Fissell W, Li L, Marchant R, Desai TA, Roy S. Hemocompatibility of silicon-based substrates for biomedical implant applications. Ann. Biomed. Eng. 2011;39: 1296-1305.
17. Huang N, Yang P, Leng YX, Chen JY, Sun H, Wang J, Wang GJ, Ding PD, Xi TF, Leng Y. Hemocompatibility of titanium oxide films. Biomaterials. 2003;24:2177-2187.
18. Feng Y, Zhao H, Zhang L, Guo J. Surface modification of biomaterials by photochemical immobilization and photograft polymerization to improve hemocompatibility. Front. Chem. Eng. China. 2010;4:372-381.
19. Werner C, Maitz MF, Sperling C. Current strategies towards hemocompatible coatings. J. Mater. Chem. 2007;17:3376-3384.
20. Ziats NP, Miller KM, Anderson JM. In vitro and in vivo interactions of cells with biomaterials. Biomaterials. 1988;9:5-13.
21. Anderson JM, McNally AK. Biocompatibility of implants: lymphocyte/macrophage interactions. Semin. Immunopathol. 2011;33:221-233.
22. André P, Delaney SM, LaRocca T, Vincent D, DeGuzman F, Jurek M, Koller B, Phillips DR, Conley PB. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J. Clin. Investigat. 2003;112:398-406.
23. Cerda-Cristerna BI, Flores H, Pozos-Guillén A, Pérez E, Sevrin C, Grandfils C. Hemocompatibility assessment of poly(2-dimethylamino ethylmethacrylate) (PDMAEMA)-based polymers. J. Control Release. 2011;153:269-277.
24. Major TC, Brant DO, Burney CP, Amoako KA, Annich GM, Meyerhoff ME, Handa H, Bartlett RH. The hemocompatibility of a nitric oxide generating polymer that catalyzes S-nitrosothiol decomposition in an extracorporeal circulation model. Biomaterials. 2011;32:5957-5969.
25. Cerda-Cristerna BI, Flores H, Pozos-Guillen A, Perez E, Sevrin C, Grandfils C. Hemocompatibility assessment of poly(2-dimethylamino ethylmethacrylate) (PDMAEMA)-based polymers. J. Control Release. 2011;153:269-277.
26. de Jonge L, Leeuwenburgh S, Wolke J, Jansen J. Organic-inorganic surface modifications for titanium implant surfaces. Pharmaceut. Res. 2008;25:2357-2369.
27. Ishihara K, Oshida H, Endo Y, Ueda T, Watanabe A, Nakabayashi N. Hemocompatibility of human whole blood on polymers with a phospholipid polar group and its mechanism. J. Biomed. Mater. Res. 1992;26:1543-1552.
28. Ekblad T, Liedberg B. Protein adsorption and surface patterning. Curr. Opin. Colloid Interf. Sci. 2010;15:499-509.
29. Faria M, Brogueira P, de Pinho MN. Sub-micron tailoring of bi-soft segment asymmetric polyurethane membrane surfaces with enhanced hemocompatibility properties. Colloids Surf. B:Biointerf. 2011;86:21-27.
30. Kim HN, Jiao A, Hwang NS, Kim MS, Kang DH, Kim D-H, Suh KY. Nanotopography-guided tissue engineering and regenerative medicine. Adv. Drug Deliv. Rev. 2012.
31. Cao H, McHugh K, Chew SY, Anderson JM. The topographical effect of electrospun nanofibrous scaffolds on the in vivo and in vitro foreign body reaction. J. Biomed. Mater. Res. Part A. 2010;93A:1151-1159.
32. Bechara S, Wadman L, Popat KC. Electroconductive polymeric nanowire templates facilitates in vitro C17.2 neural stem cell line adhesion, proliferation and differentiation. Acta Biomater. 2011;7:2892-2901.
33. McMurray RJ, Gadegaard N, Tsimbouri PM, Burgess KV, McNamara LE, Tare R, Murawski K, Kingham E, Oreffo RO, Dalby MJ. Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency. Nat. Mater. 2011;10:637-644.
34. Park K, Ju YM, Son JS, Ahn KD, Han DK. Surface modification of biodegradable electrospun nanofiber scaffolds and their interaction with fibroblasts. J. Biomater. Sci. Polym. Ed. 2007;18:369-382.
35. Seidlits SK, Lee JY, Schmidt CE. Nanostructured scaffolds for neural applications. Nanomedicine. 2008;3:183-199.
36. Bechara SL, Judson A, Popat KC. Template synthesized poly(epsilon- caprolactone) nanowire surfaces for neural tissue engineering. Biomaterials. 2010;31:3492-3501.
37. Woodruff MA, Hutmacher DW. The return of a forgotten polymer - polycaprolactone in the 21st century. Prog. Polym. Sci. 2010;35:1217-1256.
38. Liu L, Guo SR, Chang J, Ning CQ, Dong CM, Yan DY. Surface modification of polycaprolactone membrane via layer-by-layer deposition for promoting blood compatibility. J. Biomed. Mater. Res., Part B: Appl. Biomater. 2008;87B:244-250.
39. Xiang P, Li M, Zhang CY, Chen DL, Zhou ZH. Cytocompatibility of electrospun nanofiber tubular scaffolds for small diameter tissue engineering blood vessels. Int. J. Biolog. Macromol. 2011;49:281-288.
40. Li WJ, Cooper JA, Mauck RL, Tuan RS. Fabrication and characterization of six electrospun poly (alpha-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomater. 2006;2:377-385.
41. De Santis R, Gloria A, Russo T, D'Amora U, Zeppetelli S, Dionigi C, Sytcheva A, Herrmannsdörfer T, Dediu V, Ambrosio L. A basic approach toward the development of nanocomposite magnetic scaffolds for advanced bone tissue engineering. J. Appl. Polym. Sci. 2011;122:3599-3605.
42. Sangsanoh P, Waleetorncheepsawat S, Suwantong O, Wutticharoenmongkol P, Weeranantanapan O, Chuenjitbuntaworn B, Cheepsunthorn P, Pavasant P, Supaphol P. In vitro biocompatibility of Schwann cells on surfaces of biocompatible polymeric electrospun fibrous and solution-cast film scaffolds. Biomacromolecules. 2007;8:1587-1594.
43. Cooper A, Bhattarai N, Zhang MQ. Fabrication and cellular compatibility of aligned chitosan-PCL fibers for nerve tissue regeneration. Carbohyd. Polym. 2011;85:149-156.
44. Lee W, Oh JH, Park JC, Shin HI, Baek JH, Ryoo HM, Woo KM. Performance of electrospun poly (epsilon-caprolactone) fiber meshes used with mineral trioxide aggregates in a pulp capping procedure. Acta Biomater. 2012;8:2986-2995.
45. Ng KW, Khor HL, Hutmacher DW. In vitro characterization of natural and synthetic dermal matrices cultured with human dermal fibroblasts. Biomaterials. 2004;25:2807-2818.
46. Lam CX, Hutmacher DW, Schantz JT, Woodruff MA, Teoh SH. Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J. Biomed. Mater. Res. A. 2009;90: 906-919.
47. Christopher XFL, Monica MS, Swee-Hin T, Dietmar WH. Dynamics of in vitro polymer degradation of polycaprolactone-based scaffolds: accelerated versus simulated physiological conditions. Biomed. Mater. 2008;3:034108.
48. Sachlos E, Czernuszka JT. Making tissue engineering scaffolds work. Review: the application of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur. Cell Mater. 2003;5:29-39.
49. Bechara SL, Judson A, Popat KC. Template synthesized poly(?-caprolactone) nanowire surfaces for neural tissue engineering. Biomaterials. 2010;31:3492-3501.
50. Redenti S, Tao S, Yang J, Gu P, Klassen H, Saigal S, Desai T, Young MJ. Retinal tissue engineering using mouse retinal progenitor cells and a novel biodegradable, thin-film poly(e-caprolactone) nanowire scaffold. J. Ocular. Biol. Dis. Informat. 2008;1:19-29.
51. He L, Liu B, Xipeng G, Xie G, Liao S, Quan D, Cai D, Lu J, Ramakrishna S. Microstructure and properties of nano-fibrous PCL-b-PLLA scaffolds for cartilage tissue engineering. Eur. Cell Mater. 2009;18:63-74.
52. Mavis B. Compartmentalization of synthetic body fluid constituents for coating electrospun PCL nanofiber mats with different calcium phosphate phases. J. Biomech. 2011;44:7.
53. Ye L, Wu X, Mu Q, Chen B, Duan Y, Geng X, Gu Y, Zhang A, Zhang J, Feng ZG. Heparin-conjugated PCL Scaffolds fabricated by electrospinning and loaded with fibroblast growth factor 2. J. Biomater. Sci. Polym. Ed. 2010;21:21.
54. Ye L, Wu X, Duan H-Y, Geng X, Chen B, Gu Y-Q, et al. The in vitro and in vivo biocompatibility evaluation of heparin-poly(?-caprolactone) conjugate for vascular tissue engineering scaffolds. J. Biomed. Mater. Res. Part A. 2012;100A:3251-3258.
55. Murugan R, Ramakrishna S. Nano-featured scaffolds for tissue engineering: a review of spinning methodologies. Tissue Eng. 2006;12:435-447.
56. Popat KC, Porter JR, Henson A. Biodegradable poly(epsilon-caprolactone) nanowires for bone tissue engineering applications. Biomaterials. 2009;30:780-788.
57. Ruckh TT, Kumar K, Kipper MJ, Popat KC. Osteogenic differentiation of bone marrow stromal cells on poly(epsilon-caprolactone) nanofiber scaffolds. Acta Biomater. 2010;6:2949-2959.
58. Popat KC, Johnson RW, Desai TA. Characterization of vapor deposited poly (ethylene glycol) films on silicon surfaces for surface modification of microfluidic systems. J. Vacuum Sci. Technol. B. 2003;21:645-654.
59. Bechara SL, Judson A, Popat KC. Template synthesized poly(e-caprolactone) nanowire surfaces for neural tissue engineering. Biomaterials. 2010;31:3492-3501.
60. Porter JR, Henson A, Popat KC. Biodegradable poly(?-caprolactone) nanowires for bone tissue engineering applications. Biomaterials. 2009;30:780-788.
61. Zhao G, Schwartz Z, Wieland M, Rupp F, Geis-Gerstorfer J, Cochran DL, Boyan BD. High surface energy enhances cell response to titanium substrate microstructure. J. Biomed. Mater. Res. Part A. 2005;74A:49-58.
62. Roach P, Farrar D, Perry CC. Interpretation of protein adsorption: surface-induced conformational changes. J. Am. Chem. Soc. 2005;127:8168-8173.
63. Xm H, Dc C. Atomic structure and chemistry of human serum albumin. Nature. 1992 Jul 16;358:209-215.
64. Buijs J, van den Berg PAW, Lichtenbelt JWT, Norde W, Lyklema J. Adsorption dynamics of IgG and Its F(ab')2and Fc fragments studied by reflectometry. J. Colloid Interf. Sci. 1996;178: 594-605.
65. van Erp R, Linders YE, van Sommeren AP, Gribnau TC. Characterization of monoclonal antibodies physically adsorbed onto polystyrene latex particles. J. Immunol. Meth. 1992;152:191-199.
66. Nagaoka S, Kanno M, Kawakami H, Kubota S. Evaluation of blood compatibility of fluorinated polyimide by immunolabeling assay. J. Artif. Org. 2001;4:107-112.
67. Wan L-S, Xu Z-K. Polymer surfaces structured with random or aligned electrospun nanofibers to promote the adhesion of blood platelets. J. Biomed. Mater. Res. Part A. 2009;89A:168-175.
68. Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost. 2002;88:186-193.